vidarabine phosphate has been researched along with Experimental Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramis, VI; Plunkett, W | 1 |
| Geurtsen, W; Maidhof, A; Müller, WE; Schmidseder, R; Zahn, RK | 1 |
| Avramis, VI | 1 |
3 other study(ies) available for vidarabine phosphate and Experimental Leukemia
| Article | Year |
|---|---|
Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Arabinonucleotides; DNA; DNA, Neoplasm; Female; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA; Vidarabine Phosphate | 1983 |
Inhibition of DNA synthesis in permeabilized mouse P815 mast cells by arabinofuranosyladenine 5'-triphosphate.
Topics: Animals; Arabinonucleotides; Cell Membrane Permeability; Cells, Cultured; DNA Replication; DNA, Neoplasm; Eukaryotic Cells; Leukemia, Experimental; Lysophosphatidylcholines; Mast Cells; Mice; Vidarabine Phosphate | 1981 |
Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
Topics: Animals; Arabinonucleotides; Bone Marrow; DNA; Half-Life; Intestinal Mucosa; Lethal Dose 50; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Vidarabine Phosphate | 1989 |